Amendment to FDA Memorandum Circular No. 2020-001
The FDA Memorandum Circular No. 001-A-20, issued on April 16, 2020, amends the previous FDA Memorandum Circular No. 2020-001, which provided interim guidelines for issuing provisional licenses to operate (LTO) and certificates of product notification (CPN) for manufacturers of rubbing alcohol. The amendment expands the scope to include traders and distributors of rubbing alcohol products. All other applicable provisions from the original circular remain in effect. This amendment takes effect immediately.
Law Information
- Reference Number
- FDA Memorandum Circular No. 001-A-20
- Date Enacted
- Subcategory
- Food and Drugs Administration of the Philippines
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
April 16, 2020
FDA MEMORANDUM CIRCULAR NO. 001-A-20
| SUBJECT | : | Amendment to FDA Memorandum Circular No. 2020-001 Entitled Interim Guidelines for the Issuance of Provisional License to Operate (LTO) and Certificate of Product Notification (CPN) for Manufacturers of Rubbing Alcohol Products under the Center for Cosmetics Regulation and Research |
The FDA Memorandum Circular (FMC) No. 2020-001 entitled "Interim Guidelines for the Issuance of Provisional License to Operate (LTO) and Certificate of Product Notification (CPN) for Manufacturers of Rubbing Alcohol Products under the Center for Cosmetics Regulation and Research" issued on 19 March 2020, is hereby amended to include Traders and Distributors of Rubbing Alcohol Products. HTcADC
All other provisions of FMC No. 2020-001, as far as applicable, shall apply.
This Memorandum Circular shall take effect immediately.
(SGD.) ROLANDO ENRIQUE D. DOMINGO, MD.Director General
Cite This Law
Amendment to FDA Memorandum Circular No. 2020-001, FDA Memorandum Circular No. 001-A-20, Apr 16, 2020 (Philippines)
Amendment to FDA Memorandum Circular No. 2020-001, FDA Memorandum Circular No. 001-A-20 (Phil. 2020)
Related Laws
- Amendment to FDA Circular No. 2020-005 re: Prohibition on the Online Selling of Essential Emergency Medical Supplies beyond the Price Ceiling/Range set by Department Memorandum No. 2020-0058 and Department Memorandum No. 2020-0058-AFDA Circular No. 005-A-20 • Mar 20, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Amendment to Include Respiratory Therapy Devices in the List of Medical Devices Covered by FDA Circular No. 2020-009, as Amended by FDA Circular No. 2020-009-AFDA Circular No. 009-B-20 • Apr 29, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- DOH-NPC Joint Memorandum Circular No. 2020-0003DOH Memorandum Circular No. 2020-0024 • May 6, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Prohibition on the Online Selling of Essential Emergency Medical Supplies beyond the Price Ceiling/Range set by Department Memorandum No. 2020-0058 and Department Memorandum No. 2020-0058-AFDA Circular No. 005-20 • Mar 12, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Amendment of Section 3 of PPA Memorandum Circular No. 10-2020PPA Memorandum Circular No. 013-20 • Apr 3, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Memorandum Circular No. 2020-03 dated 20 March 2020DOH Department Circular No. 2020-0163 • Mar 31, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law